PapersPMID:41053771
Efficacy and safety of curcumin in patients with hand osteoarthritis: a pilot double-blinded randomised controlled trial.
No finding here moved its endpoint.
What did not
1 findingHow to read these marks →“In the between-group analysis, no significant differences were observed in VAS hand pain at rest, VAS hand pain during activity, VAS hand morning stiffness, DASH score, hand grip, pinch strength and rescue drug usage at 1, 3, and 6 months.”
- Study
- RCT
- Participants
- 27
- Dose studied
- 170 mg/day curcuminoids (turmeric powder capsules, 28.75 mg curcuminoids per capsule, two capsules three times daily) for 3 months
- Population
- patients over 50 years with hand osteoarthritis, pain during activity, between-group at 1, 3 and 6 months
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- patients over 50 years old diagnosed with hand osteoarthritis
- Participants
- 27
- Comparator
- placebo
- Duration
- 183 days
- Endpoints measured
- 15
curcumin